Brain aging and AD-like pathology in streptozotocin-induced diabetic rats

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Wang, Jian Qin ^a   Yin, Jie ^a   Song, Yan Feng ^a   Zhang, Lang ^a   Ren, Ying Xiang ^a   Wang, De Gui ^a   Gao, Li Ping ^a   Jing, Yu Hong ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHOLESTEROL; GLUCOSE; STREPTOZOCIN; SYNAPTOPHYSIN; TRIACYLGLYCEROL; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; SYP PROTEIN, RAT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; BRAIN SIZE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DENDRITIC SPINE; DISEASE COURSE; FOOD INTAKE; FOREBRAIN; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GOLGI STAIN; HIPPOCAMPUS; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERPHAGIA; HYPOTHALAMUS; INSULIN DEFICIENCY; KIDNEY FUNCTION; LEARNING; MALE; MEMORY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; POLYDIPSIA; POLYURIA; PROTEIN AGGREGATION; RAT; RISK ASSESSMENT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; WATER ABSORPTION; WEIGHT REDUCTION; AGE; AGING; ANIMAL; ANIMAL BEHAVIOR; ATROPHY; BRAIN; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; DIABETES COMPLICATIONS; EXPERIMENTAL DIABETES MELLITUS; FRONTAL LOBE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SYNAPSE; TIME;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ATROPHY; BEHAVIOR, ANIMAL; BRAIN; COGNITION; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FRONTAL LOBE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MEMORY; NERVE DEGENERATION; PEPTIDE FRAGMENTS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SYNAPSES; SYNAPTOPHYSIN; TIME FACTORS;

EID: 84907406954     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/796840     Document Type: Article

References (41)

1. J. E. Fradkin, C. C. Cowie, M. C. Hanlon, and G. P. Rodgers, "Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study," Diabetes, vol. 62, no. 12, pp. 3963-3967, 2013.
2. W. Rathmann, G. Giani, S. H.Wild et al., "Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030,"Diabetes Care, vol. 27, no. 10, pp. 2568-2569, 2004.
3. B. Bauduceau, J. Doucet, L. Bordier,C.Garcia, O. Dupuy, andH. Mayaudon, "Hypoglycaemia and dementia in diabetic patients,"Diabetes and Metabolism, vol. 36, no. 3, pp. S106-S111, 2010.
4. G. J. Francis, J. A. Martinez,W.Q. Liu et al., "Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy," Brain, vol. 131, no. 12, pp. 3311-3334, 2008.
5. Y. Zhou, Y. Luo, and J. Dai, "Axonal and dendritic changes are associated with diabetic encephalopathy in rats: an important risk factor for Alzheimer's disease," Journal of Alzheimer's Disease, vol. 34, pp. 937-947, 2013.
6. G. J. Biessels, L. P. van der Heide, A. Kamal, R. L. Bleys, and W. H. Gispen, "Ageing and diabetes: implications for brain function," European Journal of Pharmacology, vol. 441, pp. 1-14, 2002.
7. N. Z. Baquer, A. Taha, P. Kumar et al., "A metabolic and functional overview of brain aging linked to neurological disorders," Biogerontology, vol. 10, no. 4, pp. 377-413, 2009.
8. A. J. Ho, C. A. Raji, J. T. Becker et al., "The effects of physical activity, education, and body mass index on the aging brain,"Human Brain Mapping, vol. 32, no. 9, pp. 1371-1382, 2011.
9. W.-J. Zhang, Y.-F. Tan, J. T. Y. Yue, M. Vranic, and J. M. Wojtowicz, "Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats," Acta Neurologica Scandinavica, vol. 117, no. 3, pp. 205-210, 2008.
10. J. C. M. Lau, R. A. Kroes, J. R. Moskal, and R. A. Linsenmeier, "Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina,"Molecular Vision, vol. 19, pp. 1538-1553, 2013.
11. V. Calabrese, C. Cornelius, V. Leso et al., "Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes," Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 729-736, 2012.
12. W. H.Gispen andG. Biessels, "Cognition and synaptic plasticity in diabetes mellitus," Trends in Neurosciences, vol. 23, no. 11, pp. 542-549, 2000.
13. M. Hallschmid and B. Schultes, "Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?" Diabetologia, vol. 52, no. 11, pp. 2264- 2269, 2009.
14. B. Cholerton, L. D. Baker, and S. Craft, "Insulin resistance and pathological brain ageing," DiabeticMedicine, vol. 28, no. 12, pp. 1463-1475, 2011.
15. G. S. Watson, T. Bernhardt, M. A. Reger et al., "Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease,"Neurobiology of Aging, vol. 27, no. 1, pp. 38-41, 2006.
16. A. Jones, P. Kulozik, A. Ostertag, and S. Herzig, "Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes," Journal of Alzheimer's Disease, vol. 16, no. 4, pp. 787-808, 2009.
17. C. G. Jolivalt, C. A. Lee, K. K. Beiswenger et al., "Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin," Journal of Neuroscience Research, vol. 86, no. 15, pp. 3265-3274, 2008.
18. S. Cunnane, S. Nugent, M. Roy et al., "Brain fuel metabolism, aging, and Alzheimer's disease," Nutrition, vol. 27, no. 1, pp. 3- 20, 2011.
19. J. Götz, L. M. Ittner, and Y. A. Lim, "Common features between diabetes mellitus and Alzheimer's disease," Cellular and Molecular Life Sciences, vol. 66, pp. 1321-1325, 2009.
20. N. B. ElKhoury, M. Gratuze, M. A. Papon, A. Bretteville, and E. Planel, "Insulin dysfunction and Tau pathology," Frontiers in Cellular Neuroscience, vol. 8, pp. 22-28, 2014.
21. B. Kim, C. Backus, S. Oh, J. M. Hayes, and E. L. Feldman, "Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes," Endocrinology, vol. 150, no. 12, pp. 5294-5301, 2009.
22. L. Gasparini, G. K. Gouras, R. Wang et al., "Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated proteinkinase signaling," Journal of Neuroscience, vol. 21, no. 8, pp. 2561-2570, 2001.
23. L. Li and C. Hölscher, "Common pathological processes in Alzheimer disease and type 2 diabetes: a review," Brain Research Reviews, vol. 56, no. 2, pp. 384-402, 2007.
24. S. M. de la Monte and J. R. Wands, "Alzheimer's disease is type 3 diabetes-evidence reviewed," Journal of Diabetes Science and Technology, vol. 2, pp. 1101-1113, 2008.
25. Y. H. Jing, K. H. Chen, S. H. Yang, P. C. Kuo, and J. K. Chen, "Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling," Diabetes/Metabolism Research and Reviews, vol. 26, pp. 212-222, 2010.
26. Y.-H. Jing, K.-H. Chen, P.-C. Kuo, C.-C. Pao, and J.-K. Chen, "Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatmentwith resveratrol," Neuroendocrinology, vol. 98, pp. 116-127, 2013.
27. S. M. Huang, A. Mouri, H. Kokubo et al., "Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function," The Journal of Biological Chemistry, vol. 281, no. 26, pp. 17841-17951, 2006.
28. Q. Liu, J. Trotter, J. Zhang et al., "Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration,"The Journal of Neuroscience, vol. 30, pp. 17068-17078, 2010.
29. P. E. Cramer, J. R. Cirrito, D. W. Wesson et al., "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in ADmousemodels," Science, vol. 335, pp. 1503-1506, 2012.
30. E. V. Muravieva and C. M. Alberini, "Limited efficacy of propranolol on the reconsolidation of fear memories," Learning and Memory, vol. 17, no. 6, pp. 306-313, 2010.
31. J. L. Marks, D. Porte Jr., W. L. Stahl, and D. G. Baskin, "Localization of insulin receptor mRNA in rat brain by in situ hybridization," Endocrinology, vol. 127, no. 6, pp. 3234-3236, 1990.
32. R. S. Garofalo and O. M. Rosen, "Insulin and insulinlike growth factor 1 (IGF-1) receptors during central nervous system development: expression of two immunologically distinct IGF-1 receptor β subunits," Molecular and Cellular Biology, vol. 9, no. 7, pp. 2806-2817, 1989.
33. C. R. Park, R. J. Seeley, S. Craft, and S. C. Woods, "Intracerebro-ventricular insulin enhancesmemory in a passive-avoidance task," Physiology and Behavior, vol. 68, no. 4, pp. 509-514, 2000.
34. E. C. McNay, C. T. Ong, R. J. McCrimmon, J. Cresswell, J. S. Bogan, and R. S. Sherwin, "Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance,"Neurobiology of Learning and Memory, vol. 93, no. 4, pp. 546- 553, 2010.
35. R. Suzuki, K. Lee, E. Jing et al., "Diabetes and insulin in regulation of brain cholesterol metabolism," Cell Metabolism, vol. 12, no. 6, pp. 567-579, 2010.
36. S. D. Ryan, S. N. Whitehead, L. A. Swayne et al., "Amyloid- β42 signals tau hyperphosphorylation and compromises neuronalviability by disrupting alkylacylglycerophosphocholine metabolism," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 49, pp. 20936-20941, 2009.
37. W. Zhao andM. Townsend, "Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease," Biochimica et Biophysica Acta, vol. 1792, no. 5, pp. 482-496, 2009.
38. X. Q. Bao, N. Li, T. Wang et al., "FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation,"PLoS One, vol. 8, no. 11, Article ID e78033, 2013.
39. S. Ito, S. Ohtsuki, S. Murata et al., "Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-beta peptide in mouse brain capillary endothelial cells," Journal of Alzheimer's Disease, vol. 38, no. 1, pp. 185-200, 2014.
40. Y. Liu, H. Liu, J. Yang et al., "Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats,"Neuroscience, vol. 153, pp. 796-802, 2008.
41. M. A. Papon, N. B. El Khoury, F. Marcouiller et al., "Deregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice," Diabetes, vol. 62, pp. 609-617, 2013.